AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Pro Medicus Ltd (ASX:PME)
327.98 AUD
-2.500 0.757%| Previous Close (in AUD) | 330.48 |
|---|---|
| Change | -2.500 0.757% |
| 52 W H/L (in AUD) | 336.000/120.924 |
| EBITDA (in AUD) | 134.047M |
| PE Ratio | 359.22 |
| Volume | 160288 |
| Diluted Eps TTM | 0.92 |
| Total Assets (in AUD) | 257.426M |
|---|---|
| Total Liabilities (in AUD) | 69.698M |
| Revenue TTM (in AUD) | 184.581M |
| Cash (in AUD) | 60.062M |
| Market Cap (in AUD) | 34,522.935 M |
| Revenue Per Share TTM | 1.767 |
| Gross Profit TTM (in AUD) | 184.3M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Pro Medicus Ltd
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Exec. Director | NA |
| 2. | Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Exec. Director | NA |
| 3. | Mr. Clayton James Hatch CPA, B.Comm, CPA | CFO & Company Sec. | NA |
| 4. | Dr. Malte Westerhoff | GM of Europe & Global CTO | NA |
| 5. | Mr. Brad Levin | GM of North America & Global Head of Marketing | NA |
| 6. | Mr. Sean Lambright | Global Head of Sales - Visage Imaging Inc | NA |
| 7. | Ms. Teresa Gschwind | Global Head of Customer Service of Visage Imaging Inc. | NA |
| 8. | Dr. Sam Aaron Hupert M.B.B.S., M.D. | Co-Founder, CEO, MD & Executive Director | NA |
| 9. | Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. | Co-Founder, Technology Director & Executive Director | NA |
| 10. | Mr. Clayton James Hatch B.Comm, CPA, CPA | Chief Financial Officer | NA |
Peers
Sector: Healthcare
Industry: Health Information Services
| Company | Change (AUD) | Price (AUD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
CGS
CogState Ltd |
+0.060 3.409% | 1.77 | 29.330 | 19.011 | 6.330 | 4.335 | 3.299 | 12.147 |
|
ONE
Oneview Healthcare PLC |
0.000 0.000% | 0.24 | 0.000 | 0.000 | 20.332 | 8.526 | 10.136 | -3.525 |
|
ALC
Alcidion Group Ltd |
+0.010 9.091% | 0.105 | 0.000 | 105.263 | 4.145 | 1.652 | 3.780 | 53.699 |
|
AYA
Artrya Ltd |
+0.105 10.294% | 1.03 | 0.000 | 0.000 | 8981.335 | 7.169 | 0.000 | 0.326 |
Income Statement
(Currency in AUD)| Breakdown | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 | 30-06-2019 |
|---|---|---|---|---|---|
| Income Before Tax | 86.126M | 63.079M | 42.872M | 30.02M | 26.123M |
| Minority Interest | - | - | - | - | - |
| Net Income | 60.648M | 44.442M | 30.85M | 23.076M | 23.076M |
| Selling General Administrative | 24.065M | 15.4M | 13.534M | 12.853M | 12.129M |
| Gross Profit | 124.243M | 92.936M | 67.347M | 56.425M | 48.667M |
| Reconciled Depreciation | 7.926M | 7.316M | 7.197M | 7.683M | 6.084M |
| Ebit | 83.761M | 62.326M | 42.334M | 30.025M | 25.439M |
| Ebitda | 91.687M | 69.642M | 49.531M | 37.708M | 31.523M |
| Depreciation And Amortization | 7.926M | 7.316M | 7.197M | 7.683M | 6.084M |
| Operating Income | 84.08M | 61.313M | 42.632M | 30.066M | 25.439M |
| Other Operating Expenses | 40.117M | 30.101M | 24.212M | 26.263M | 24.637M |
| Interest Expense | 0.386M | 0.649M | 0.538M | 0.005M | 0.684M |
| Tax Provision | 25.478M | 18.637M | 12.022M | 6.944M | 6.998M |
| Interest Income | 2.431M | 0.649M | 0.18M | 0.172M | 0.244M |
| Net Interest Income | 2.431M | 0.649M | 0.18M | 0.172M | 0.244M |
| Income Tax Expense | 25.478M | 18.637M | 12.022M | 6.944M | 6.998M |
| Total Revenue | 124.787M | 93.401M | 67.837M | 56.78M | 50.076M |
| Total Operating Expenses | 40.482M | 30.61M | 25.013M | 26.4M | 23.228M |
| Cost Of Revenue | 0.544M | 0.465M | 0.49M | 0.355M | 1.409M |
| Total Other Income Expense Net | -0.066M | 0.104M | 0.36M | -0.177M | 0.684M |
| Net Income From Continuing Ops | 60.648M | 44.442M | 30.85M | 23.076M | 19.125M |
| Net Income Applicable To Common Shares | 60.648M | 44.442M | 30.85M | 23.076M | 19.125M |
Balance Sheet
(Currency in AUD)| Breakdown | 30-06-2024 | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 |
|---|---|---|---|---|---|
| Total Assets | 257.426M | 202.135M | 157.051M | 125.574M | 95.645M |
| Intangible Assets | 20.071M | 21.349M | 22.293M | 20.009M | 18.839M |
| Other Current Assets | 1.89M | 0.783M | 0.449M | 1.568M | 1.026M |
| Total Liab | 69.698M | 63.359M | 55.319M | 43.891M | 35.462M |
| Total Stockholder Equity | 187.728M | 138.776M | 101.732M | 81.683M | 60.183M |
| Other Current Liab | 15.214M | 16.562M | 14.485M | 7.287M | 4.134M |
| Common Stock | 23.649M | 1.959M | 1.959M | 1.962M | 1.962M |
| Capital Stock | 23.649M | 1.959M | 1.959M | 1.962M | 1.962M |
| Retained Earnings | 173.356M | 127.116M | 92.576M | 66.922M | 49.62M |
| Good Will | - | - | - | - | - |
| Other Assets | 0M | 12.448M | 47.188M | 43.032M | 40.526M |
| Cash | 60.062M | 91.248M | 63.656M | 42.039M | 43.413M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 34.557M | 30.851M | 26.86M | 17.619M | 12.716M |
| Current Deferred Revenue | 17.051M | 12.602M | 10.128M | 8.886M | 7.225M |
| Net Debt | -57.993M | -89.397M | -61.377M | -39.421M | -41.137M |
| Short Term Debt | 0.553M | 0.654M | 0.604M | 0.574M | 0.522M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 2.069M | 1.851M | 2.279M | 2.618M | 2.276M |
| Other Stockholder Equity | - | -129.075M | -94.535M | -68.884M | -51.582M |
| Property Plant Equipment | - | 2.187M | 2.602M | 3.014M | 2.848M |
| Total Current Assets | 206.562M | 163.79M | 119.824M | 87.566M | 61.483M |
| Long Term Investments | 7.336M | - | - | - | - |
| Short Term Investments | 95.363M | 30.247M | 26.898M | 19.777M | 19.777M |
| Net Receivables | 49.198M | 39.882M | 27.44M | 22.841M | 13.844M |
| Long Term Debt | - | - | - | - | - |
| Inventory | 0.049M | 0.055M | 0.077M | 0.034M | 0.035M |
| Accounts Payable | 1.739M | 1.033M | 1.643M | 0.872M | 0.835M |
| Accumulated Other Comprehensive Income | -9.277M | 9.701M | 7.197M | 12.799M | 8.601M |
| Non Currrent Assets Other | 0.04M | 2.603M | 1.466M | 1.385M | 0.993M |
| Non Current Assets Total | 50.864M | 38.345M | 37.227M | 38.008M | 34.162M |
| Capital Lease Obligations | 2.069M | 1.851M | 2.279M | 2.618M | 2.276M |
| Long Term Debt Total | - | 1.197M | 1.675M | 2.044M | 1.754M |
Cash Flow
(Currency in AUD)| Breakdown | 30-06-2023 | 30-06-2022 | 30-06-2021 | 30-06-2020 | 30-06-2019 |
|---|---|---|---|---|---|
| Investments | -7.557M | -8.533M | -19.704M | -7.699M | -7.305M |
| Total Cashflows From Investing Activities | -7.557M | -16.907M | -27.217M | -7.699M | -7.305M |
| Total Cash From Financing Activities | -27.527M | -23.314M | -14.049M | -12.315M | -9.843M |
| Net Income | 60.648M | 44.442M | 30.85M | 23.076M | 19.125M |
| Change In Cash | 27.592M | 21.617M | -1.374M | 11.098M | 7.077M |
| Begin Period Cash Flow | 63.656M | 42.039M | 43.413M | 32.315M | 25.238M |
| End Period Cash Flow | 91.248M | 63.656M | 42.039M | 43.413M | 32.315M |
| Total Cash From Operating Activities | 62.535M | 61.576M | 38.84M | 31.42M | 24.658M |
| Depreciation | 0.834M | 0.813M | 0.803M | 0.845M | 6.084M |
| Other Cashflows From Investing Activities | -1.111M | 0.649M | 0.18M | 0.172M | 0.244M |
| Dividends Paid | 26.108M | 18.788M | 13.548M | 10.916M | 9.843M |
| Change To Inventory | 0.022M | -0.043M | 0.001M | -0.004M | 0.023M |
| Sale Purchase Of Stock | -0.845M | -4.017M | -4.017M | -0.842M | -0.842M |
| Other Cashflows From Financing Activities | -0.574M | -0.509M | -0.501M | -0.557M | 0.842M |
| Capital Expenditures | 6.446M | 9.023M | 7.693M | 7.871M | 7.549M |
| Change In Working Capital | -13.456M | -3.634M | -9.538M | 4.795M | -8.961M |
| Other Non Cash Items | 1.053M | 16.321M | 7.187M | 7.499M | 5.342M |
| Free Cash Flow | 56.089M | 52.553M | 31.147M | 23.549M | 17.109M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | DFA Asia Pacific Small Company Series | 4 years ago | 300101 |
| 2. | iShares MSCI EAFE Small Cap ETF | 4 years ago | 204600 |
| 3. | Global X Fds-Global X Telemedicine & Digital Health ETF | 4 years ago | 263305 |
| 4. | Aberdeen Standard SICAV I-Asian Smaller Companies Fd | 4 years ago | 445426 |
| 5. | Goldman Sachs International Small Cap Insights Fund | 4 years ago | 770749 |
| 6. | iShares Core MSCI EAFE ETF | 4 years ago | 233735 |
| 7. | Wasatch International Opportunities Fund | 4 years ago | 396745 |
| 8. | Brinker Capital Destinations Tr-Destinations International Equity Fd | 4 years ago | 305250 |
| 9. | Vanguard International Stock Index-Total Intl Stock Indx | 4 years ago | 707611 |
| 10. | Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 4 years ago | 265091 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...